Quantitative analysis of HER2-mediated effects on HER2 and epidermal growth factor receptor endocytosis: distribution of homo- and heterodimers depends on relative HER2 levels - PubMed (original) (raw)
. 2003 Jun 27;278(26):23343-51.
doi: 10.1074/jbc.M300477200. Epub 2003 Apr 9.
Affiliations
- PMID: 12686539
- DOI: 10.1074/jbc.M300477200
Free article
Quantitative analysis of HER2-mediated effects on HER2 and epidermal growth factor receptor endocytosis: distribution of homo- and heterodimers depends on relative HER2 levels
Bart S Hendriks et al. J Biol Chem. 2003.
Free article
Abstract
Endocytic trafficking plays an important role in the regulation of the epidermal growth factor receptor (EGFR) family. Many cell types express multiple EGFR family members (including EGFR, HER2, HER3, and/or HER4) that interact to form an array of homo- and heterodimers. Differential trafficking of these receptors should strongly affect signaling through this system by changing substrate access and heterodimerization efficiency. Because of the complexity of these dynamic processes, we used a quantitative and computational model to understand their integrated operation. Parameters characterizing EGFR and HER2 interactions were determined using experimental data obtained from mammary epithelial cells constructed to express different levels of HER2, enabling us to estimate receptor-specific internalization rate constants and dimer uncoupling rate constants. Significant novel results obtained from this work are as follows: first, that EGFR homodimerization and EGFR/HER2 heterodimerization occur with comparable affinities; second, that EGFR/HER2 heterodimers traffic as single entities. Furthermore, model predictions of the relationship of HER2 expression levels to consequent distribution of EGFR homodimers and EGFR/HER2 heterodimers suggest that the levels of HER2 found on normal cells are barely at the threshold necessary to drive efficient heterodimerization. Thus, altering HER2 concentrations, either overall or local, could provide an effective mechanism for regulating EGFR/HER2 heterodimerization and may explain why HER2 overexpression found in some cancers has such a profound effect on cell physiology.
Similar articles
- A new model system identifies epidermal growth factor receptor-human epidermal growth factor receptor 2 (HER2) and HER2-human epidermal growth factor receptor 3 heterodimers as potent inducers of oesophageal epithelial cell invasion.
Fichter CD, Przypadlo CM, Buck A, Herbener N, Riedel B, Schäfer L, Nakagawa H, Walch A, Reinheckel T, Werner M, Lassmann S. Fichter CD, et al. J Pathol. 2017 Dec;243(4):481-495. doi: 10.1002/path.4987. Epub 2017 Nov 5. J Pathol. 2017. PMID: 28940194 Free PMC article. - Parsing ERK activation reveals quantitatively equivalent contributions from epidermal growth factor receptor and HER2 in human mammary epithelial cells.
Hendriks BS, Orr G, Wells A, Wiley HS, Lauffenburger DA. Hendriks BS, et al. J Biol Chem. 2005 Feb 18;280(7):6157-69. doi: 10.1074/jbc.M410491200. Epub 2004 Nov 29. J Biol Chem. 2005. PMID: 15572377 - Model-based analysis of HER activation in cells co-expressing EGFR, HER2 and HER3.
Shankaran H, Zhang Y, Tan Y, Resat H. Shankaran H, et al. PLoS Comput Biol. 2013;9(8):e1003201. doi: 10.1371/journal.pcbi.1003201. Epub 2013 Aug 22. PLoS Comput Biol. 2013. PMID: 23990774 Free PMC article. - Heterodimerization and functional interaction between EGF receptor family members: a new signaling paradigm with implications for breast cancer research.
Earp HS, Dawson TL, Li X, Yu H. Earp HS, et al. Breast Cancer Res Treat. 1995 Jul;35(1):115-32. doi: 10.1007/BF00694752. Breast Cancer Res Treat. 1995. PMID: 7612898 Review. - Interplay of the iron-regulated metastasis suppressor NDRG1 with epidermal growth factor receptor (EGFR) and oncogenic signaling.
Menezes SV, Sahni S, Kovacevic Z, Richardson DR. Menezes SV, et al. J Biol Chem. 2017 Aug 4;292(31):12772-12782. doi: 10.1074/jbc.R117.776393. Epub 2017 Jun 14. J Biol Chem. 2017. PMID: 28615452 Free PMC article. Review.
Cited by
- Mathematical modeling of drug-induced receptor internalization in the HER2-positive SKBR3 breast cancer cell-line.
Fehling-Kaschek M, Peckys DB, Kaschek D, Timmer J, Jonge N. Fehling-Kaschek M, et al. Sci Rep. 2019 Sep 3;9(1):12709. doi: 10.1038/s41598-019-49019-x. Sci Rep. 2019. PMID: 31481718 Free PMC article. - Modeling the effects of HER/ErbB1-3 coexpression on receptor dimerization and biological response.
Shankaran H, Wiley HS, Resat H. Shankaran H, et al. Biophys J. 2006 Jun 1;90(11):3993-4009. doi: 10.1529/biophysj.105.080580. Epub 2006 Mar 13. Biophys J. 2006. PMID: 16533841 Free PMC article. - Influence of affinity and antigen internalization on the uptake and penetration of Anti-HER2 antibodies in solid tumors.
Rudnick SI, Lou J, Shaller CC, Tang Y, Klein-Szanto AJ, Weiner LM, Marks JD, Adams GP. Rudnick SI, et al. Cancer Res. 2011 Mar 15;71(6):2250-9. doi: 10.1158/0008-5472.CAN-10-2277. Cancer Res. 2011. PMID: 21406401 Free PMC article. - Input-output behavior of ErbB signaling pathways as revealed by a mass action model trained against dynamic data.
Chen WW, Schoeberl B, Jasper PJ, Niepel M, Nielsen UB, Lauffenburger DA, Sorger PK. Chen WW, et al. Mol Syst Biol. 2009;5:239. doi: 10.1038/msb.2008.74. Epub 2009 Jan 20. Mol Syst Biol. 2009. PMID: 19156131 Free PMC article. - Lipidated Peptidomimetic Ligand-Functionalized HER2 Targeted Liposome as Nano-Carrier Designed for Doxorubicin Delivery in Cancer Therapy.
Naik H, Sonju JJ, Singh S, Chatzistamou I, Shrestha L, Gauthier T, Jois S. Naik H, et al. Pharmaceuticals (Basel). 2021 Mar 6;14(3):221. doi: 10.3390/ph14030221. Pharmaceuticals (Basel). 2021. PMID: 33800723 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous